F

Federico Mingozzi

Spark Therapeutics (United States)

ORCID: 0000-0002-6607-0058

53 papers and 2.2k citations.

PubIndex Score43Top 57% · seniorHow it's scored

53Publications

2.2kTotal Citations

First publication: 2001First senior author: 2010

Top publicationsby citations

Exposure to wild-type AAV drives distinct capsid immunity profiles in humans

Klaudia Kuranda, Federico Mingozzi|Journal of Clinical Investigation|2018

Cited by 100

Indexing the rest of 53 publications…